One-step quantitative RT-PCR assay with armored RNA controls for detection of SARS-CoV-2.
Ontology highlight
ABSTRACT: Coronavirus disease 2019 (COVID-19) has become pandemic since March 11, 2020. Thus, development and integration in clinics of fast and sensitive diagnostic tools are essential. The aim of the study is a development and evaluation of a one-step quantitative reverse transcription-polymerase chain reaction (RT-qPCR) assay (COVID-19 Amp) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection with an armored positive control and internal controls constructed from synthetic MS2-phage-based RNA particles. The COVID-19 Amp assay limit of detection was 103 copies/ml, the analytical specificity was 100%. A total of 109 biological samples were examined using COVID-19 Amp and World Health Organization (WHO)-based assay. Discordance in nine samples was observed (negative
SUBMITTER: Goncharova EA
PROVIDER: S-EPMC7537076 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA